1. Dapagliflozin improves Myocardial Flow Reserve in patients with Type 2 Diabetes: the DAPAHEART Trial. (3rd October 2022) Authors: D'Amario, D; Leccisotti, L; Cinti, F; Sorice, G P; Lorusso, M; Guzzardi, M A; Mezza, T; Cocchi, C; Capece, U; Indovina, L; Ferraro, P M; Iozzo, P; Giordano, A; Giaccari, A; Crea, F Journal: European heart journal Issue: Volume 43(2022)Supplement 2 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗